机构:
Univ Paris 05, Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Fac Med,INSERM CIC 9201, Paris, FranceUniv Paris 05, Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Fac Med,INSERM CIC 9201, Paris, France
Briet, Marie
[1
]
Schiffrin, Ernesto L.
论文数: 0引用数: 0
h-index: 0
机构:
Sir Mortimer B Davis Jewish Hosp, Dept Med, Montreal, PQ, Canada
McGill Univ, Lady Davis Inst Med Res, Montreal, PQ, CanadaUniv Paris 05, Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Fac Med,INSERM CIC 9201, Paris, France
Schiffrin, Ernesto L.
[2
,3
]
机构:
[1] Univ Paris 05, Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Fac Med,INSERM CIC 9201, Paris, France
[2] Sir Mortimer B Davis Jewish Hosp, Dept Med, Montreal, PQ, Canada
[3] McGill Univ, Lady Davis Inst Med Res, Montreal, PQ, Canada
Aldosterone exerts direct effects on the vascular system by inducing oxidative stress, inflammation, hypertrophic remodeling, fibrosis, and endothelial dysfunction. Aldosterone exerts its effects through genomic and nongenomic pathways in a mineralocorticoid receptor (MR)-dependent or independent manner. Other aldosterone receptors such as GPR30 have been identified. A tight relation exists between the aldosterone and angiotensin II pathways, as well as with the endothelin-1 system. There is a correlation between plasma levels of aldosterone and cardiovascular risk. Recently, an increasing body of evidence has underlined the importance of aldosterone in cardiovascular complications associated with the metabolic syndrome, such as arterial remodeling and endothelial dysfunction. Blockade of MR is an increasingly used evidence-based therapy for many forms of cardiovascular disease, including hypertension, heart failure, chronic kidney disease, and diabetes mellitus. Copyright (c) 2012 S. Karger AG, Basel
机构:
Hop Europeen Georges Pompidou, APHP, INSERM, Clin Invest Ctr 9201, F-75015 Paris, France
Univ Paris 05, Fac Med, Paris, FranceHop Europeen Georges Pompidou, APHP, INSERM, Clin Invest Ctr 9201, F-75015 Paris, France
Azizi, Michel
;
Menard, Joel
论文数: 0引用数: 0
h-index: 0
机构:
Univ Paris 05, Fac Med, Paris, FranceHop Europeen Georges Pompidou, APHP, INSERM, Clin Invest Ctr 9201, F-75015 Paris, France
Menard, Joel
;
Peyrard, Severine
论文数: 0引用数: 0
h-index: 0
机构:
Univ Paris 05, Fac Med, Paris, FranceHop Europeen Georges Pompidou, APHP, INSERM, Clin Invest Ctr 9201, F-75015 Paris, France
Peyrard, Severine
;
Watson, Catherine
论文数: 0引用数: 0
h-index: 0
机构:
Novartis Pharmaceut, E Hanover, NJ USAHop Europeen Georges Pompidou, APHP, INSERM, Clin Invest Ctr 9201, F-75015 Paris, France
Watson, Catherine
;
Plouin, Pierre-Francois
论文数: 0引用数: 0
h-index: 0
机构:
Univ Paris 05, Fac Med, Paris, FranceHop Europeen Georges Pompidou, APHP, INSERM, Clin Invest Ctr 9201, F-75015 Paris, France
机构:
Hop Europeen Georges Pompidou, APHP, INSERM, Clin Invest Ctr 9201, F-75015 Paris, France
Univ Paris 05, Fac Med, Paris, FranceHop Europeen Georges Pompidou, APHP, INSERM, Clin Invest Ctr 9201, F-75015 Paris, France
Azizi, Michel
;
Menard, Joel
论文数: 0引用数: 0
h-index: 0
机构:
Univ Paris 05, Fac Med, Paris, FranceHop Europeen Georges Pompidou, APHP, INSERM, Clin Invest Ctr 9201, F-75015 Paris, France
Menard, Joel
;
Peyrard, Severine
论文数: 0引用数: 0
h-index: 0
机构:
Univ Paris 05, Fac Med, Paris, FranceHop Europeen Georges Pompidou, APHP, INSERM, Clin Invest Ctr 9201, F-75015 Paris, France
Peyrard, Severine
;
Watson, Catherine
论文数: 0引用数: 0
h-index: 0
机构:
Novartis Pharmaceut, E Hanover, NJ USAHop Europeen Georges Pompidou, APHP, INSERM, Clin Invest Ctr 9201, F-75015 Paris, France
Watson, Catherine
;
Plouin, Pierre-Francois
论文数: 0引用数: 0
h-index: 0
机构:
Univ Paris 05, Fac Med, Paris, FranceHop Europeen Georges Pompidou, APHP, INSERM, Clin Invest Ctr 9201, F-75015 Paris, France